Blockchain Registration Transaction Record

GeoVax to Present Clinical Data at Industry Events in April 2025

GeoVax Labs, Inc. to showcase GEO-CM04S1 and Gedeptin programs at industry events in April 2025. Learn about their innovative vaccine development and cancer therapies. Stay updated on their latest research advancements in immunotherapies and infectious disease treatments.

This news matters as it highlights the innovative work of GeoVax Labs, Inc. in developing novel vaccines and therapies. The presentation of data on their programs at prestigious industry events demonstrates their commitment to advancing immunotherapies and vaccines against cancers and infectious diseases. The comparison of their COVID-19 vaccine candidate to an approved vaccine and the focus on gene therapy in solid tumors showcase the company's cutting-edge research efforts.